Lumendo AG
SwitzerlandFDA applicant, unverified
- Devices
- 2
What Lumendo AG makes
Lumendo AG manufactures endovascular devices for treating vascular conditions, including the Fibercure system for stent reinforcement and the Endofill solution for vascular sealing and embolization. These products are designed to enhance structural support and occlusion in blood vessels during interventional procedures.
The company’s portfolio is regulated under FDA Class II devices, with products authorised via the 510(k) pathway. The devices are listed in the FDA’s 510(k) registry. Lumendo AG is based in the United States.
Catalogue
Frequently asked questions
How many devices does Lumendo AG have in the registry?
The registry currently lists 2 devices for Lumendo AG. Devices recorded under merged duplicate company entries are counted once.
Which registries list Lumendo AG's devices?
Among its 2 most recently registered devices, Lumendo AG has devices listed in FDA 510(k) (2 devices).
What risk classes do Lumendo AG's devices fall under?
Among its 2 most recently registered devices, the classes recorded for Lumendo AG's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Lumendo AG in the registry?
The most recently registered devices listed for Lumendo AG include Fibercure and Endofill.